Circulating Tumor Cells as an Independent Predictor of Survival in Advanced Gastric Cancer

Annals of Surgical Oncology

Volumn 22, Issue 12, 2015, Pages 3954-3961

  Okabe, H ^a   Tsunoda, S ^a   Hosogi, H ^a   Hisamori, S ^a   Tanaka, E ^a   Tanaka, S ^a   Sakai, Y ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; TUMOR MARKER;

A WAVE; ADVANCED CANCER; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER PROGNOSIS; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CELL ISOLATION; CIRCULATING TUMOR CELL; DISTANT METASTASIS; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; IMMUNOMAGNETIC SEPARATION; INDUCTION CHEMOTHERAPY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; MULTIMODALITY CANCER THERAPY; PERITONEUM LAVAGE; PROGRESSION FREE SURVIVAL; PROSPECTIVE STUDY; STOMACH CANCER; THERAPY EFFECT; ADENOCARCINOMA; ASCITES FLUID; BLOOD; CELL COUNT; DISEASE FREE SURVIVAL; EVALUATION STUDY; GASTRECTOMY; MIDDLE AGED; PATHOLOGY; RECEIVER OPERATING CHARACTERISTIC; RESPONSE EVALUATION CRITERIA IN SOLID TUMORS; SECONDARY; STOMACH NEOPLASMS; SURVIVAL RATE; TUMOR EMBOLISM;

ADENOCARCINOMA; AGED; ASCITIC FLUID; BIOMARKERS, TUMOR; CELL COUNT; DISEASE-FREE SURVIVAL; FEMALE; GASTRECTOMY; HUMANS; IMMUNOMAGNETIC SEPARATION; INDUCTION CHEMOTHERAPY; MALE; MIDDLE AGED; NEOPLASTIC CELLS, CIRCULATING; PROSPECTIVE STUDIES; RESPONSE EVALUATION CRITERIA IN SOLID TUMORS; ROC CURVE; STOMACH NEOPLASMS; SURVIVAL RATE;

EID: 84943360065     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-015-4483-6     Document Type: Article

References (19)

1. Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2010 (ver. 3). Gastric Cancer. 2011;14:113–23.
2. Cunningham D, Allum W, Stenning S, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med. 2006;355:11–20.
3. Satoh S, Hasegawa S, Ozaki N, et al. Retrospective analysis of 45 consecutive patients with advanced gastric cancer treated with neoadjuvant chemotherapy using an S-1/CDDP combination. Gastric Cancer. 2006;9:129–35.
4. Satoh S, Okabe H, Teramukai S, et al. Phase II trial of combined treatment consisting of preoperative S-1 plus cisplatin followed by gastrectomy and postoperative S-1 for stage IV gastric cancer. Gastric Cancer. 2012;15:61–9.
5. Okabe H, Ueda S, Obama K, et al. Induction chemotherapy with S-1 plus cisplatin followed by surgery for treatment of gastric cancer with peritoneal dissemination. Ann Surg Oncol. 2009;16:3227–36.
6. Cristofanilli M, Budd GT, Ellis MJ, et al. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med. 2004;351:781–91.
7. Sastre J, Maestro ML, Puente J, et al. Circulating tumor cells in colorectal cancer: correlation with clinical and pathological variables. Ann Oncol. 2008;19:935–8.
8. Uenosono Y, Arigami T, Kozono T, et al. Clinical significance of circulating tumor cells in peripheral blood from patients with gastric cancer. Cancer. 2013;119:3984–91.
9. Matsusaka S, Chìn K, Ogura M, et al. Circulating tumor cells as a surrogate marker for determining response to chemotherapy in patients with advanced gastric cancer. Cancer Sci. 2010;101:1067–1071.
10. Bando E, Yonemura Y, Takeshita Y, et al. Intraoperative lavage for cytological examination in 1,297 patients with gastric carcinoma. Am J Surg. 1999;178:256–62.
11. Edge S, Byrd D, Compton C, et al. AJCC Cancer Staging Manual. 7th ed. Springer, New York 2009.
12. Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma. 3rd English edition. Gastric Cancer. 2011;14:101–12.
13. Kodera Y, Ito S, Mochizuki Y, et al. Long-term follow-up of patients who were positive for peritoneal lavage cytology: final report from the CCOG0301 study. Gastric Cancer. 2012;15:335–7.
14. Kuramoto M, Shimada S, Ikeshima S, et al. Extensive intraoperative peritoneal lavage as a standard prophylactic strategy for peritoneal recurrence in patients with gastric carcinoma. Ann Surg. 2009;250:242–6.
15. International Union Against Cancer. TNM Classification of Malignant Tumours. 7th ed. Wiley-Blackwell, Hoboken, NJ 2009.
16. Therasse P, Arbuck S, Eisenhauer E, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst. 2000;92:205–16.
17. Huang X, Gao P, Sun J, et al. Clinicopathological and prognostic significance of circulating tumor cells in patients with gastric cancer: a meta-analysis. Int J Cancer. 2015;136:21–33.
18. Ajani JA, Bentrem DJ, Besh S, et al. Gastric cancer, version 2.2013: featured updates to the NCCN Guidelines. J Natl Compr Canc Netw. 2013;11:531–46.
19. Hiraiwa K, Takeuchi H, Hasegawa H, et al. Clinical significance of circulating tumor cells in blood from patients with gastrointestinal cancers. Ann Surg Oncol. 2008;15:3092–100.